NEWS

Enanta Pharmaceuticals, Inc’s publication on the International Journal of Gastroenterology.

News Release 2019.07.03

SMC announces that Enanta Pharmaceuticals, Inc. has published the results of a study using the STAM model in the International Journal of Gastroenterology.

 

Title: Characterization of EDP-305, a Highly Potent and Selective Farnesoid X Receptor Agonist, for the Treatment of Non-alcoholic Steatohepatitis

 

Read more…. http://www.sciencepublishinggroup.com/journal/paperinfo?journalid=282&doi=10.11648/j.ijg.20190301.12